Venture Capital

Overview

Osler has a leading venture capital team dedicated to helping investors and emerging companies recognize, develop and realize upon significant and innovative venture capital opportunities. We have worked on more than 150 VC deals over the past three years, representing more than $1.6 billion of investment in Canadian private companies.

We advise clients in the information technology, life sciences, biotechnology, cleantech and alternative energy sectors and have worked with numerous SR&ED-based financings and collaborative research arrangements that access these and related funding sources. Our team advises both investors and Canadian companies accessing private capital on the unique issues involved in venture capital deals. In addition to working with Canadian funds, we also advise many U.S. funds on their Canadian investments and in M&A transactions for portfolio companies.

Cross-Border Expertise / Mergers and Acquisitions

Osler has pioneered some of Canada’s most innovative structures to accommodate the unique regulatory and tax constraints that affect cross-border investments. We have the know-how and experience to help U.S. and other foreign investors take equity positions in Canadian companies in ways that satisfy their tax objectives (both on the way into a Canadian venture and also with an eye to any potential exit transaction) and that also preserve relevant tax attributes of the Canadian business. Whether as counsel to a Canadian business or to the lead investors in that business, we have played a significant role in many of the notable M&A transactions involving venture-backed Canadian companies.

Fund Formation

Our venture capital team has worked closely with the managers of leading Canadian-focused funds on their fund formation activities. Our strong deal flow means that we are always on top of market practice, including issues as to fund structure, manager compensation, governance arrangements for the management/GP entity and the amount and structuring of carried interests. We also advise Canadian and U.S. private equity funds on acquisitions and divestitures of portfolio investments, on managing third-party funds and on secondary sale transactions.

Emerging Companies

In addition to our work with established companies, we work closely with emerging companies throughout their growth cycle to provide practical and cost-effective advice on all aspects of their development, including corporate structure, financing, IP, human resources, commercial matters and the preparation for and execution of IPO and M&A transactions.

DownloadDownload

Related Expertise

Robert Lehodey Q.C.

Partner, Corporate
Calgary

Ed Vandenberg

Partner, Corporate
Ottawa

Chad Bayne

Partner, Corporate
Toronto

Shahir Guindi

National Co-chair
Montréal
  • Lightspeed POS Inc.

    Lightspeed POS Inc. in a US$166 million transaction involving an acquisition of shares by the Caisse de dépôt et placement du Québec

  • Sensibill Inc.

    Sensibill Inc. in connection with its $17.3 million Series A Financing

  • Meta Inc.

    Meta Inc. in its acquisition by Chan Zuckerberg Initiative LLC

  • Resson Aerospace Corporation

    Resson Aerospace Corporation in connection with its US$11 million Series B Financing

  • Universe

    Universe in its acquisition by Live Nation

  • HootSuite

    HootSuite in connection with its $165M series B financing, the largest venture capital financing in Canadian history.

  • Affinium Pharmaceuticals

    Affinium Pharmaceuticals in its BIA restructuring and subsequent VC financings, including post-restructuring exchangeable share VC financing, with aggregate proceeds in excess of $35 million.

  • Preferred share investors

    Preferred share investors (in a syndicate led by Genesys Ventures and iNovia Capital) in the $17 million Class A preferred share financing of Allostera Pharma.

  • Ambit Biosciences

    Ambit Biosciences in the establishment of a Canadian research entity and through multiple VC financing rounds with aggregate proceeds in excess of $50 million.

  • Preferred share investors

    Preferred share investors (in a syndicate led by Celtic House) of Diablo Technologies Inc.on its $15 million Class B financing.

  • Find More